国际呼吸杂志
國際呼吸雜誌
국제호흡잡지
INTERNATIONAL JOURNAL OF RESPIRATION
2015年
10期
796-800
,共5页
肺动脉高压%药物治疗
肺動脈高壓%藥物治療
폐동맥고압%약물치료
Pulmonary arterial hypertension%Drug treatment
肺动脉高压(pulmonary arterial hypertension,PAH)是一种渐进性疾病,其特点为肺血管重塑,导致肺动脉压增高和右心室衰竭。近年来随着人们对 PAH 发病机制认识地不断提高,针对 PAH发病各环节的治疗均取得了长足进展,从而改变了 PAH 患者的命运。
肺動脈高壓(pulmonary arterial hypertension,PAH)是一種漸進性疾病,其特點為肺血管重塑,導緻肺動脈壓增高和右心室衰竭。近年來隨著人們對 PAH 髮病機製認識地不斷提高,針對 PAH髮病各環節的治療均取得瞭長足進展,從而改變瞭 PAH 患者的命運。
폐동맥고압(pulmonary arterial hypertension,PAH)시일충점진성질병,기특점위폐혈관중소,도치폐동맥압증고화우심실쇠갈。근년래수착인문대 PAH 발병궤제인식지불단제고,침대 PAH발병각배절적치료균취득료장족진전,종이개변료 PAH 환자적명운。
Pulmonary arterial hypertension is a progressive disease characterized by pulmonary vascular remodeling,which may lead to increased pulmonary artery pressure and right ventricular heart failure.With the increasing understanding of the pathogenesis of PAH in recent years,considerable progress has been made for the treatment of various aspects of PAH,and the fate of PAH patients has been changed.
